C2 and ischemia reperfusion injury: In the recent past, we have cloned and purified one IgM NAb, designated C2, a mAb that recognizes an epitope expressed on a subset of phospholipids (PL), and shown that C2 mAb specifically bind to the intestine (47), brain (48), and heart following ischemia-reperfusion injury (49).